-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Sigyn Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q2 2016 to Q3 2025.
- Sigyn Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 62.1 %, a 41.6% decline year-over-year.
- Sigyn Therapeutics, Inc. annual Return On Equity for 2024 was 83.1 %, a 38% decline from 2023.
- Sigyn Therapeutics, Inc. annual Return On Equity for 2023 was 134 %, a 36.4% decline from 2022.
- Sigyn Therapeutics, Inc. annual Return On Equity for 2022 was 211 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)